Molybdenum for Health & Longevity - Quick Reference Sheet

Molybdenum for Health & Longevity

Created on 09/22/2026 – Quick Reference based on Evidence Review created using AI4L / Opus 5 – Audit

Molybdenum is an essential trace mineral found in legumes, grains, dairy, and organ meats, where it switches on enzymes that clear sulfites and help process certain drugs. An ordinary diet supplies more than enough, and there is little sign that extra does anything useful in someone who already has enough. Excess molybdenum depletes copper and, at very high intakes, can trigger gout-like symptoms. Sufficiency, not supplementation, is what matters. (Full Review)

Protocol

Primary approach — dietary sufficiency
Varied diet, no supplement
Best-supported position: diet delivers well above the 45 mcg/day requirement.
Targeted low-dose supplementation — integrative approach
45–150 mcg/day
Short courses, occasionally up to ~500 mcg/day; popularized within integrative practice rather than backed by controlled trials.
Form selection
Sodium molybdate, ammonium molybdate, or glycinate
All well absorbed (~85–93%); no form has demonstrated clinical superiority. A single daily dose is standard.
Time to effect
Genuine deficiency
Days to weeks
Biochemical correction of sulfite handling and symptom reversal after repletion.
Already-adequate adult
No perceptible effect
There is no deficit to correct.

Benefits

Contraindications
  • Gout or hyperuricemia
  • Wilson's disease on copper-lowering therapy (except under specialist direction)
  • Gallstones
  • Reduced kidney function (eGFR <60 mL/min/1.73 m²)
  • Pregnancy or breastfeeding, beyond the 50 mcg requirement
  • Diagnosed copper deficiency
Key Interactions
  • Copper supplements and copper-rich regimens
  • Prescription copper-lowering drugs (tetrathiomolybdate/ALXN1840, penicillamine, trientine)
  • Xanthine-oxidase inhibitors (allopurinol, febuxostat)
  • Acetaminophen and other aldehyde-oxidase substrates
  • High-sulfur intake (sulfite-preserved foods, high-dose sulfur-amino-acid or MSM supplements)
  • Supplements with additive copper-lowering effect (high-dose zinc)

Risk & Side Effects

  • High: Copper depletion and copper–molybdenum antagonism
  • Medium: Gout-like syndrome and elevated uric acid at high intake
  • Low: Acute neuro-psychiatric toxicity from megadose supplements; reduced fertility and growth signals
  • Speculative: Bone and connective-tissue effects; interference with drug metabolism

Monitoring

Marker Target Why
Serum copper 80–120 mcg/dL (mid-range preferred) Detects molybdenum-driven copper depletion
Ceruloplasmin 20–35 mg/dL Confirms functional copper status
Serum uric acid 3.5–5.5 mg/dL Flags molybdenum-related hyperuricemia/gout risk
Complete blood count Hemoglobin >13 g/dL (men) / >12 g/dL (women); normal neutrophils Catches anemia/neutropenia from copper deficiency
Plasma/serum molybdenum ~0.3–2.0 ng/mL (lab-dependent) Confirms excess exposure in suspected toxicity

Cadence: Supplemental users only — copper status and uric acid at baseline, again at roughly 8–12 weeks of continued use, then every 6–12 months if use continues; prompt discontinuation and recheck if any abnormality or symptom appears.

Qualitative Assessment

  • Absence of new joint pain or gout flares during use
  • Stable energy and no new fatigue, pallor, or easy bruising (early copper-deficiency clues)
  • For a sulfite-sensitivity trial specifically: fewer flushing, wheezing, or headache reactions to sulfite-containing foods and wine
  • No cognitive or mood changes